Immunex Faces Skeptical Fed. Circ. In Antibody Patent Fight
A Federal Circuit panel appeared skeptical Wednesday that the Patent Trial and Appeal Board ignored vital evidence in construing a key claim term to invalidate an Immunex antibody patent at the...To view the full article, register now.
Already a subscriber? Click here to view full article